Ayerra, LeyreAbellanas, Miguel AngelVidaurre, ClaraBasurco, LeyreTavira, AdrianaLuquin, EstherClavero, PedroMengual, ElisaCollantes, MariaPeñuelas, Ivande Martin-Esteban, Samuel RuizGrether, UweHillard, Cecilia J.Romero, JulianHervás-Stubbs, SandraAymerich, Maria S.2025-12-192025-12-192025-08Ayerra, L, Abellanas, M A, Vidaurre, C, Basurco, L, Tavira, A, Luquin, E, Clavero, P, Mengual, E, Collantes, M, Peñuelas, I, de Martin-Esteban, S R, Grether, U, Hillard, C J, Romero, J, Hervás-Stubbs, S & Aymerich, M S 2025, 'Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease', Brain, Behavior, and Immunity, vol. 128, pp. 600-611. https://doi.org/10.1016/j.bbi.2025.04.0370889-1591unpaywall: 10.1016/j.bbi.2025.04.037https://hdl.handle.net/10641/6805Publisher Copyright: © 2025 The Author(s)127524331enghttp://creativecommons.org/licenses/by-nc-nd/4.0/CD4 T cellsCannabinoid receptor type 2Endocannabinoid systemMicrogliaNeuroprotectionParkinson's diseaseImmunologyEndocrine and Autonomic SystemsBehavioral NeuroscienceJournal ArticleYesyesjournal articleopen access10.1016/j.bbi.2025.04.037https://www.scopus.com/pages/publications/105004306558https://www.scopus.com/pages/publications/105004306558#tab=citedBy